Epstein Secrets

tant DNI for Strategic Communications Amanda Shoch said Ratcliffe's "top priority is our nation's security." Meanwhile, the Washington Times (10/8, Blake, 492K) reports Rep. Elissa Slotkin (D-MI), who before being elected to Congress served in the CIA and in the Office of the Director of National Int

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "

rity." Meanwhile, the Washington Times <https://wvvw.washingtontimes.com/news/2020/oct/8/elissa-slotkin-former- cia-analyst-accuses-dni-johnk (10/8, Blake, 492K) reports Rep. Elissa Slotkin (D-MI), who before being elected to Congress served in the CIA and in the Office of the Director of National Inte

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "f

tant DNI for Strategic Communications Amanda Shoch said Ratcliffe's "top priority is our nation's security." Meanwhile, the Washington Times (10/8, Blake, 492K) reports Rep. Elissa Slotkin (D-MI), who before being elected to Congress served in the CIA and in the Office of the Director of National Int

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "

by county, state and federal governments." Poll Shows 650/0 Believe US Handling Coronavirus Worse Than Other Countries. The Washington Times (8/4, Blake, 492K) reports an Ipsos poll of 1,115 adults conducted for NPR July 30-31 shows that "roughly two-thirds [65%] of Americans surveyed believe the U.S

Lilly Seeking Volunteers For Antibody Drug Trials. On NBC Nightly NewsVi (8/4, story 8, 1:45, 6.1M), Tom Costello reported, "The NIH and drugmaker Eli Lilly are tonight looking for 2,000 volunteers for antibody drug trials to treat patients suffering from the ravages of COVID. One trial involves patients

tant DNI for Strategic Communications Amanda Shoch said Ratcliffe's "top priority is our nation's security." Meanwhile, the Washington Times (10/8, Blake, 492K) reports Rep. Elissa Slotkin (D-MI), who before being elected to Congress served in the CIA and in the Office of the Director of National Int

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "